Challenge Programme — AMR Diagnostics for LRTI
Supports diagnostic innovations for antimicrobial resistant respiratory infections in Danish consortia.
The Novo Nordisk Foundation's Challenge Programme 2027 — AMR Diagnostics for Lower Respiratory Tract Infections (LRTI) theme funds large research consortia to advance next-generation diagnostics for antimicrobial-resistant pathogens causing lower respiratory tract infections. Antimicrobial resistance in respiratory pathogens represents a critical and growing gap in clinical microbiology; the call …
Large-consortium research to develop next-generation diagnostics for antimicrobial-resistant pathogens causing lower respiratory tract infections, with international scope and Danish institutional anchor required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline